1.Covid-19 drug portfolio of domestic majors witnesses a sharp rise amidst the pandemic : Pharma news – 20 August: The sale of prescription drugs has dropped drastically and this decline is due to the lesser generation of prescriptions. This remains to be a cause of concern to many pharma companies. But, their business however remains […]
Atrimed Pharma receives ICMR’s approval for the clinical trials its plant-based Covid-19 drugs Pharma News – 16 August: Atrimed Pharma is a Bengaluru-based pharmaceutical company. This drug firm mainly focuses on the development of phytopharmaceuticals and plant-based medications. It had recently received the ICMR’s[1] approval for conducting clinical trials on three of its phytomolecules. The
Cipla’s Goa plant begins production of Remdesivir to meet the increased demand: Pharma News – 13 August: The surge in the number of Covid-19 cases has increased the demand for Remdesivir. As current production capacity remains insufficient to meet this growing demand, pharmaceutical companies are ramping up their production. In accordance with this scenario, pharma
Glenmark plans to launch Fabiflu 400 mg for the treatment of Covid-19: Pharma News – 9 August: Glenmark Pharmaceuticals announced the launch of Fabiflu 400 mg in the Indian market (On 6 August 2020). Fabiflu is an oral antiviral drug that was initially launched in the 200 mg strength. It is used for the treatment
Lupin pharmaceuticals recall Cefdinir for oral suspension from the US market : Pharma News – 6 August: Lupin Pharmaceuticals Inc., based in Baltimore, USA[1] had initiated a countrywide recall of its antibiotic on 2 July 2020. This generic antibiotic is called Cefdinir for oral suspension USP, 250 mg /5mL. It is packaged in 60 mL
Pfizer and BioNTech’s vaccine reaches the last stages of human trials : Pharma News – 30 July: Pfizer and BioNTech have been proactive in their search for a Covid-19 vaccine. The initial stages of the clinical trial of their lead Covid-19 vaccine have shown promising results. Following this, the companies have announced that the beginning
Brinton Pharma has received DCGI’s approval for marketing Faviton in India: Pharma News – 26 July: Favipiravir was approved by the DCGI[1] in June 2020 under the emergency use authorization. This medication was found to be effective in treating Covid-19 patients. Clinical evidence obtained from various parts of the globe has proved its efficacy in
AstraZeneca’s Covid-19 vaccine passes the initial human trials: Pharma News 23 July- British drug firm, AstraZeneca has been working in collaboration with Oxford University for producing a Covid-19 vaccine. This vaccine is called as AZD1222. AZD1222 is a chimpanzee adenovirus viral vector vaccine. The adenovirus of this vaccine has been genetically modified to code for
Table of Contents Glenmark Pharma has reduced the price of Fabiflu tablets by 27%: Pharma news 16 July 2020 Glenmark Pharmaceuticals had launched its antiviral drug, Favipiravir, in the Indian market in June 2020. Initially, the price per tablet of Fabiflu was set at Rs.103. This drug was approved for the treatment of mild to
Pfizer and BioNTech’s mRNA vaccine will most likely hit the markets by the end of 2020: Pfizer and BioNTech had collaborated to produce an experimental Covid-19 vaccine called BNT162b1. Preliminary human testing of this vaccine had shown promising results against the SARS-CoV-2[1]. The phase 1/2 trials of this vaccine were conducted to establish its safety.
